MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications
- 13 October 2022
- journal article
- research article
- Published by Elsevier in Current Opinion in Virology
- Vol. 56, 101272
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 AI143620)
- National Institutes of Health (R21 AI153666)
This publication has 66 references indexed in Scilit:
- Epstein–Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BADCancer Letters, 2015
- EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTENOncogene, 2014
- MicroRNA-34a: a potential therapeutic target in human cancerCell Death & Disease, 2014
- The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphomaInfectious Agents and Cancer, 2014
- EBV-Encoded miR-BART20-5p and miR-BART8 Inhibit the IFN-γ–STAT1 Pathway Associated with Disease Progression in Nasal NK-Cell LymphomaThe American Journal of Pathology, 2014
- Evolutionary Conservation of Primate Lymphocryptovirus MicroRNA TargetsJournal of Virology, 2014
- MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and CancerImmunity, 2013
- The Epstein-Barr Virus (EBV)-Induced Tumor Suppressor MicroRNA MiR-34a Is Growth Promoting in EBV-Infected B CellsJournal of Virology, 2012
- Differential regulation of miR-21 and miR-146a by Epstein–Barr virus-encoded EBNA2Leukemia, 2012
- Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B CellsPLOS Pathogens, 2010